References
- Bofill Rodriguez M, Lethaby A, Jordan V. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2020;6:CD002126.
- Bitzer J, Serrani M, Lahav A. Women’s attitudes towards heavy menstrual bleeding, and their impact on quality of life. Open Access J Contracept. 2013;4:21–28.
- National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management. NICE guideline NG88. London: National Institute for Health and Care Excellence; 2018. (last updated 2020).
- Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2016;2016:CD003855.
- Munro MG, Critchley HO, Broder MS, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113:3–13.
- Hallberg L, Högdahl AM, Nilsson L, et al. Menstrual blood loss – a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand. 1966;45:320–351.
- Byles JE, Hanrahan PF, Schofield MJ. ‘It would be good to know you’re not alone’: the health care needs of women with menstrual symptoms. Fam Pract. 1997;14:249–254.
- Copher R, Le Nestour E, Law A, et al. Retrospective analysis of variation in heavy menstrual bleeding treatments by age and underlying cause. Curr Med Res Opin. 2013;29(2):127–139.
- Fraser IS, Mansour D, Breymann C, et al. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Int J Gynaecol Obstet. 2015;128:196–200.
- Committee on Practice Bulletins—Gynecology. Practice bulletin no. 136: management of abnormal uterine bleeding associated with ovulatory dysfunction. Obstet Gynecol. 2013;122:176–185.
- Singh S, Best C, Dunn S, et al. Abnormal uterine bleeding in pre-menopausal women. J Obstet Gynaecol Can. 2013;35:473–475.
- Schrijvers G, van Hoorn A, Huiskes N. The care pathway: concepts and theories: an introduction. Int J Integr Care. 2012;12:e192.
- Bidmon S, Terlutter R. Gender differences in searching for health information on the internet and the virtual patient–physician relationship in Germany: exploratory results on how men and women differ and why. J Med Internet Res. 2015;17:e156.
- Office for National Statistics. Internet access – households and individuals, Great Britain: 2019. Statistical Bulletin, 12 August 2019. London: Office for National Statistics; 2019. [cited 28 July 2020]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/householdcharacteristics/homeinternetandsocialmediausage/bulletins/internetaccesshouseholdsandindividuals/2019
- Karlsson TS, Marions LB, Edlund MG. Heavy menstrual bleeding significantly affects quality of life. Acta Obstet Gynecol Scand. 2014;93:52–57.
- Lukes AS, Moore KA, Muse KN, et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol. 2010;116(4):865–875.
- Endrikat J, Shapiro H, Lukkari-Lax E, et al. A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia. J Obstet Gynaecol Can. 2009;31(4):340–347.
- Shabaan MM, Zakherah MS, El-Nashar SA, et al. Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial. Contraception. 2011;83(1):48–54.
- Fraser IS, Parke S, Mellinger U, et al. Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest. Eur J Contracept Reprod Health Care. 2011;16:258–269.
- Reid PC, Virtanen-Kari S. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. BJOG. 2005;112(8):1121–1125.
- Kaunitz AM, Bissonnette F, Monteiro I, et al. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol. 2010;116(3):625–632. Published correction: Obstet Gynecol. 2010;116:999.
- Lunardi Rocha AL, Cristina França Ferreira M, Mara Lamaita R, et al. Heavy menstrual bleeding: a global survey of health care practitioners’ perceptions. Eur J Contracept Reprod Health Care. 2018;23(4):288–294.
- Schneider CE. The practice of autonomy: patients, doctors, and medical decisions. New York (NY): Oxford University Press; 1998.
- Schivone GB, Glish LL. Contraceptive counseling for continuation and satisfaction. Curr Opin Obstet Gynecol. 2017;29:443–448.
- Christiansen R, Emiliussen J. Manipulation and free will in shared decision making. J Eval Clin Pract. 2020;26:403–408.
- Zandstra D, Busser JAS, Aarts JWM, et al. Interventions to support shared decision-making for women with heavy menstrual bleeding: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2017;211:156–163.
- National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management. Clinical guideline CG44. London: National Institute for Health and Care Excellence; 2007. (last updated 2016; replaced by NICE guideline NG88).